D-Streptamine, O-3-deoxy-4-C-methyl-3-(methylamino)-β-L-arabinopyranosyl-(1→6)-O-[2,6-diamino-2,3,4,6-tetradeoxy-α-D-glycero-hex-4-enopyranosyl-(1→4)]-2-deoxy-, sulfate (2:5) (salt) cas no:53179-09-2
Synonyms: (2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxy-cyclohexyl]oxy-5-methyl-4-methylamino-oxane-3,5-diol;32385-11-8;Salvamina;Sisomicine [INN-French];Sch-13475;Sisomycin;O-3-Deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1-4)-O-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-glycero-hex-4-enopyranosyl-(1-6))-2-deoxy-L-streptamine;Prestwick_847;Siseptin (TN);D-Streptamine,O-3-deoxy-4-C-methyl-3- (methylamino)-a-L-arabinopyranosyl-(1f6)- O-[2,6-diamino-2,3,4,6-tetradeoxy-R-Dglycero- hex-4-enopyranosyl-(1f4)]-2-deoxy-,sulfate (2:5) (salt);Baymicine;Sisomicin sulfate [USAN:JAN];
NameD-Streptamine, O-3-deoxy-4-C-methyl-3-(methylamino)-β-L-arabinopyranosyl-(1→6)-O-[2,6-diamino-2,3,4,6-tetradeoxy-α-D-glycero-hex-4-enopyranosyl-(1→4)]-2-deoxy-, sulfate (2:5) (salt)
CAS53179-09-2
Synonyms(2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxy-cyclohexyl]oxy-5-methyl-4-methylamino-oxane-3,5-diol;32385-11-8;Salvamina;Sisomicine [INN-French];Sch-13475;Sisomycin;O-3-Deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1-4)-O-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-glycero-hex-4-enopyranosyl-(1-6))-2-deoxy-L-streptamine;Prestwick_847;Siseptin (TN);D-Streptamine,O-3-deoxy-4-C-methyl-3- (methylamino)-a-L-arabinopyranosyl-(1f6)- O-[2,6-diamino-2,3,4,6-tetradeoxy-R-Dglycero- hex-4-enopyranosyl-(1f4)]-2-deoxy-,sulfate (2:5) (salt);Baymicine;Sisomicin sulfate [USAN:JAN];
EINECS(EC#)258-414-4
Molecular Formula2(C19H37N5O7).5(H2SO4)
Molecular Weight937.89
storage temp2-8°C
Hazard T,Xi
Risk 61-20/21/22-36/37/38
Safety
Poison by intravenous, intramuscular, intraperitoneal, and subcutaneous routes. See also SULFATES. When heated to decomposition it emits very toxic fumes of SOx and NOx.
Hazard CodesT,Xi
Risk Statements 61-20/21/22-36/37/38
R61:May cause harm to the unborn child.
R20/21/22:Harmful by inhalation, in contact with skin and if swallowed.
R36/37/38:Irritating to eyes, respiratory system and skin.
Safety Statements 53-22-36/37/39-45-36-26
S22:Do not breathe dust.
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S36:Wear suitable protective clothing.
S53:Avoid exposure - obtain special instructions before use.
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection.
WGK Germany 3
RTECS WK2288000
1. |
|
scu-rat LD50:500 mg/kg
|
|
JZKEDZ Jitchuken, Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Preclinical Reports. 4 (1978),107. |
2. |
|
ivn-rat LD50:49 mg/kg
|
|
JZKEDZ Jitchuken, Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Preclinical Reports. 4 (1978),107. |
3. |
|
ims-rat LD50:404 mg/kg
|
|
JZKEDZ Jitchuken, Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Preclinical Reports. 4 (1978),107. |
4. |
|
ipr-mus LD50:221 mg/kg
|
|
JANTAJ Journal of Antibiotics. 23 (1970),551. |
5. |
|
scu-mus LD50:272 mg/kg
|
|
JZKEDZ Jitchuken, Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Preclinical Reports. 4 (1978),107. |
6. |
|
ivn-mus LD50:34 mg/kg
|
|
JANTAJ Journal of Antibiotics. 23 (1970),551. |
7. |
|
ims-mus LD50:280 mg/kg
|
|
JZKEDZ Jitchuken, Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Preclinical Reports. 4 (1978),107. |